We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NBRGU:NASDAQNewbridge Acquisition Limited Analysis

Data as of 2026-07-16 - not real-time

$10.25

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The price is currently sitting above its 20‑day (≈10.23), 50‑day (≈10.13) and 200‑day (≈10.05) simple moving averages, indicating a short‑term bullish alignment, while the 14‑day RSI around 62 suggests moderate upward momentum. However, the MACD histogram is negative and the MACD signal is flagged bearish, revealing underlying weakness despite the price rise. The stock’s beta is essentially flat, pointing to minimal market‑wide price sensitivity, and 30‑day volatility of roughly 6% is modest. Volume has been sharply decreasing, with daily trades under 100 shares, creating a pronounced liquidity constraint. Moreover, the price‑to‑book ratio sits near 15, a level that is high for a shell company that reports zero revenue, negative cash flow, and no earnings. These fundamentals – zero operating results, negative cash flow, and a high PB – starkly contrast the technical bullish cues.
Given the extreme liquidity risk, the absence of any operating performance, and an overvalued balance‑sheet profile, the upside potential appears limited. The market sentiment index is in “Extreme Greed,” but that likely reflects speculative SPAC dynamics rather than intrinsic value. Consequently, the prudent stance is to avoid exposure until a credible merger or asset acquisition materializes.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD divergence despite price above SMAs
  • Severely decreasing trading volume
  • High price‑to‑book ratio with no earnings

Medium Term

1–3 years
Cautious
Model confidence: 8/10

Key Factors

  • Continued liquidity constraints
  • Negative operating and free cash flow
  • Lack of any disclosed merger target or business plan

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Persistent overvaluation relative to book value
  • No revenue generation or profit outlook
  • Potential regulatory and sector‑specific headwinds for shell entities

Key Metrics & Analysis

Financial Health

ROE-3.07%
ROA-0.79%
Debt/Equity45.65
P/B Ratio15.1
Op. Cash Flow$-379736
Free Cash Flow$-237335
Industry P/E17.9

Technical Analysis

TrendBullish
RSI61.9
Support$10.01
Resistance$10.32
MA 20$10.23
MA 50$10.13
MA 200$10.05
MACDBearish
VolumeDecreasing
Fear & Greed Index92.98

Valuation

GradeOvervalued
TypeBlend

Risk Assessment

Beta0.05
Volatility6.04%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.